澳獅環球(01540.HK)獅子山集團(01127.HK)執董對新型肺炎病毒測試呈陽性反應
澳獅環球(01540.HK)及獅子山集團(01127.HK)公布,執行董事劉竹堅於上週五(13日)對新型冠狀病毒測試呈陽性反應,目前情況穩定,正在香港留院接受治療。公司之香港總辦事處已由一間專業公司進行徹底的清潔及消毒,現與衛生防護中心緊密合作,以確保曾經與劉竹堅接觸的公司員工及業務夥伴得知有關消息。
澳獅環球表示,由於公司主要業務在澳洲運作,故營運預期將不會因此而受到重大干擾。獅子山集團則指,劉竹堅症狀相對輕微,公司業務將不會受到重大干擾。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.